ATE224369T1 - BICYCLOLACTAM COMPOUNDS THEIR USE AND INTERMEDIATE PRODUCTS FOR THEIR PRODUCTION - Google Patents
BICYCLOLACTAM COMPOUNDS THEIR USE AND INTERMEDIATE PRODUCTS FOR THEIR PRODUCTIONInfo
- Publication number
- ATE224369T1 ATE224369T1 AT96916350T AT96916350T ATE224369T1 AT E224369 T1 ATE224369 T1 AT E224369T1 AT 96916350 T AT96916350 T AT 96916350T AT 96916350 T AT96916350 T AT 96916350T AT E224369 T1 ATE224369 T1 AT E224369T1
- Authority
- AT
- Austria
- Prior art keywords
- effect
- production
- intermediate products
- bicyclolactam
- bicyclolactam compounds
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/52—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring condensed with a ring other than six-membered
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/20—Oxygen atoms
- C07D215/22—Oxygen atoms attached in position 2 or 4
- C07D215/227—Oxygen atoms attached in position 2 or 4 only one oxygen atom which is attached in position 2
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D221/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
- C07D221/02—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
- C07D221/04—Ortho- or peri-condensed ring systems
- C07D221/06—Ring systems of three rings
- C07D221/16—Ring systems of three rings containing carbocyclic rings other than six-membered
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Anesthesiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Other In-Based Heterocyclic Compounds (AREA)
- Indole Compounds (AREA)
- Quinoline Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Pyrrole Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Bicyclolactam compounds represented by general formula (1) are useful as the active ingredient of medicines having an excellent anxiolytic effect and a high safety with little side effects such as a hypnotic effect, a muscle relaxing effect, a sedative effect, etc. In said formula, R represents oxo or -OR<1> (wherein R<1> represents hydrogen or acyl); A represents one of the following groups (2) and (3); Q represents hydrogen or lower alkyl; l is 1 or 2, m is 0 or 1; and n is 0, 1 or 2, provided that m and n are not 0 at the same time; R<2> represents optionally substituted benzoyl.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP17032995 | 1995-06-12 | ||
JP27465495A JP3161948B2 (en) | 1995-06-12 | 1995-09-27 | Bicyclolactam compound |
PCT/JP1996/001565 WO1996041796A1 (en) | 1995-06-12 | 1996-06-07 | Bicyclolactam compounds, use of the same and intermediate in the production of the same |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE224369T1 true ATE224369T1 (en) | 2002-10-15 |
Family
ID=26493354
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT96916350T ATE224369T1 (en) | 1995-06-12 | 1996-06-07 | BICYCLOLACTAM COMPOUNDS THEIR USE AND INTERMEDIATE PRODUCTS FOR THEIR PRODUCTION |
Country Status (10)
Country | Link |
---|---|
JP (1) | JP3161948B2 (en) |
KR (1) | KR100220172B1 (en) |
AT (1) | ATE224369T1 (en) |
AU (1) | AU697656B2 (en) |
CA (1) | CA2197178C (en) |
DE (1) | DE69623747T2 (en) |
DK (1) | DK0790237T3 (en) |
ES (1) | ES2183956T3 (en) |
PT (1) | PT790237E (en) |
WO (1) | WO1996041796A1 (en) |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0466933B1 (en) * | 1990-02-02 | 1995-11-22 | Taiho Pharmaceutical Company Limited | Bicyclolactam derivative |
PT713702E (en) * | 1994-03-28 | 2005-01-31 | Taiho Pharmaceutical Co Ltd | ANSIOLITIC AGENT |
-
1995
- 1995-09-27 JP JP27465495A patent/JP3161948B2/en not_active Expired - Fee Related
-
1996
- 1996-06-07 CA CA002197178A patent/CA2197178C/en not_active Expired - Fee Related
- 1996-06-07 DK DK96916350T patent/DK0790237T3/en active
- 1996-06-07 ES ES96916350T patent/ES2183956T3/en not_active Expired - Lifetime
- 1996-06-07 PT PT96916350T patent/PT790237E/en unknown
- 1996-06-07 KR KR1019970700925A patent/KR100220172B1/en not_active IP Right Cessation
- 1996-06-07 AU AU59118/96A patent/AU697656B2/en not_active Ceased
- 1996-06-07 WO PCT/JP1996/001565 patent/WO1996041796A1/en active IP Right Grant
- 1996-06-07 DE DE69623747T patent/DE69623747T2/en not_active Expired - Fee Related
- 1996-06-07 AT AT96916350T patent/ATE224369T1/en not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
ES2183956T3 (en) | 2003-04-01 |
KR100220172B1 (en) | 1999-09-01 |
AU5911896A (en) | 1997-01-09 |
JP3161948B2 (en) | 2001-04-25 |
WO1996041796A1 (en) | 1996-12-27 |
CA2197178C (en) | 2001-05-01 |
KR970704686A (en) | 1997-09-06 |
CA2197178A1 (en) | 1996-12-27 |
DE69623747D1 (en) | 2002-10-24 |
PT790237E (en) | 2003-02-28 |
JPH0959251A (en) | 1997-03-04 |
AU697656B2 (en) | 1998-10-15 |
DE69623747T2 (en) | 2003-05-22 |
DK0790237T3 (en) | 2002-10-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE59103595D1 (en) | NEW PHOSPHOLIPID DERIVATIVES OF NUCLEOSIDES, THEIR PRODUCTION AND THEIR USE AS ANTIVIRAL MEDICINAL PRODUCTS. | |
ES2095432T3 (en) | DERIVATIVES OF 2,4-TIAZOLIDIN-DIONA, ITS PREPARATION PROCEDURE AND THE PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM. | |
ATE176237T1 (en) | SPHINGOGLYCOLIPID AND USE THEREOF | |
ATE197704T1 (en) | BICYCLIC AMIDE DERIVATIVES AND THEIR USE AS MUSCLE RELAXING COMPOUNDS | |
DK0649405T3 (en) | 22-en-25-oxa derivatives in the Vitamin D series, process for their preparation, pharmaceutical preparations containing these derivatives and use of such preparations as pharmaceuticals. | |
DE69313771D1 (en) | Carbazolone derivatives and process for their preparation | |
ATE224369T1 (en) | BICYCLOLACTAM COMPOUNDS THEIR USE AND INTERMEDIATE PRODUCTS FOR THEIR PRODUCTION | |
ATE113030T1 (en) | HYDROXYALKANCARBONIC ACID DERIVATIVES AND THEIR USE. | |
AR004484A1 (en) | NEW 1,2,3,4-TETRAHIDRO-2-NAFTALENAMINAS FENILO-SUBSTITUTED IN THE AROMATIC RING, ITS PREPARATION, ITS THERAPEUTIC APPLICATIONS AND THE PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM. | |
ATE118212T1 (en) | 1-(ALKOXYBENZYL)PIPERAZINEAMIDE, METHOD FOR THE PRODUCTION THEREOF AND PHARMACEUTICAL COMPOSITIONS CONTAINING SAME. | |
EP0790237A4 (en) | Bicyclolactam compounds, use of the same and intermediate in the production of the same | |
AU3443593A (en) | 4-oxo- and 4H-imidazo(5,1-C)(1,4)benzoxazines useful as benzodiazepine receptor-binding agents | |
ES2095431T3 (en) | N- (ISOQUINOLEIN-5-IL) -SULFONIL-AZACICLOALCANOS, ITS PREPARATION PROCEDURE AND THE PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM. | |
ES2117003T3 (en) | OLIGOPEPTIDICAL DERIVATIVES OF HIPOXANTINA GIVEN WITH IMMUNOMODULATING ACTIVITY, AND PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM. | |
DE69127880D1 (en) | Pyrrolo [2,3-d] azepine derivatives, process for their preparation and pharmaceutical preparations containing them | |
DE59606725D1 (en) | SUBSTITUTED PHENYLAMIDINE, MEDICINAL PRODUCTS CONTAINING THESE COMPOUNDS AND METHOD FOR THE PRODUCTION THEREOF | |
NZ229300A (en) | Substituted-2-ethenyl-3,4,5,6-tetrahydrothieno (4,3,2-cf)(3)benzazepine derivatives and pharmaceutical compositions | |
ATE42291T1 (en) | SPIRO(INDOLO(1,7-AB>(1,5>BENZODIAZEPIN-2,4'PIPERIDINE> AND INTERMEDIATE PRODUCTS, PROCESS FOR THEIR MANUFACTURE AND USE AS MEDICINAL PRODUCTS. | |
NO974206D0 (en) | 17-difluoromethyl-estratrienes | |
ZW6889A1 (en) | &-adrenergic receptor antagonists | |
ES2081763B1 (en) | PURIFIED FORM OF STREPTOGRAMS, THEIR PREPARATION AND THE PHARMACEUTICAL COMPOSITIONS THAT CONTAIN IT. | |
MX9207396A (en) | NOVEL IMIDAZOLES. | |
ZW6989A1 (en) | &-adrenergic receptor antagonists | |
EP0551952A3 (en) | 17-aryl-substituted steroidal compounds active on the cardiovascular system |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
UEP | Publication of translation of european patent specification | ||
REN | Ceased due to non-payment of the annual fee |